A detailed history of Enzi Wealth transactions in Abbott Laboratories stock. As of the latest transaction made, Enzi Wealth holds 2,785 shares of ABT stock, worth $313,702. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,785
Previous 2,656 4.86%
Holding current value
$313,702
Previous $301,000 3.99%
% of portfolio
0.13%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$100.73 - $112.44 $12,994 - $14,504
129 Added 4.86%
2,785 $289,000
Q1 2024

Apr 16, 2024

BUY
$109.52 - $120.96 $109 - $120
1 Added 0.04%
2,656 $301,000
Q3 2023

Oct 16, 2023

SELL
$95.53 - $114.62 $859 - $1,031
-9 Reduced 0.34%
2,655 $257,000
Q2 2023

Jul 14, 2023

BUY
$100.78 - $112.29 $1,007 - $1,122
10 Added 0.38%
2,664 $290,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $95 - $111
1 Added 0.04%
2,654 $0
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $256,704 - $297,215
2,653 New
2,653 $276,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Enzi Wealth Portfolio

Follow Enzi Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enzi Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Enzi Wealth with notifications on news.